Trenbolone Hexahydrobenzylcarbonate (TREN HEX) was first released by the French-based Negma Laboratories in the late 1960’s under the trade name Parabolan. This represents the first and only Trenbolone hormone to ever exist in human grade form. Parabolan was prescribed for many years in cases of malnutrition. It was also prescribed to treat osteoporosis in some cases, as well as in the treatment of cachexia. However, in 1997 Negma would pull Parabolan from the market. As the first human grade pharmaceutical Trenbolone compound, it was also the last.
Parabolan is very similar to the more popular Trenbolone Acetate (Fina) compound. The only difference is the ester attached, as Parabolan will provide a much slower release of Trenbolone requiring fewer injections. The functional traits and characteristics of the Trenbolone hormone do not change based on the attached ester.
However, when used incorrectly, these advantages are mitigated by some real-life consequences. Trenbolone can severally influence muscle development, making it probably the best compound for keeping up and adding quality bulk. In the first place, trenbolone can incredibly expand the degree of IGF-1 inside the muscle tissue. It additionally causes muscle satellite cells, those liable for fixing harmed muscle filaments, to be more touchy to IGF-1 and other development factors. The measure of DNA per muscle cell may likewise be essentially expanded by utilizing trenbolone. Trenbolone has a powerful restricting partiality for the androgen receptor too, in any event, unparalleled that of testosterone. This upholds the attestation that trenbolone is incredibly anabolic as by restricting to the androgen receptor a compound can enact the anabolic and ward components upon the androgen receptor, one of the numerous ways that anabolic steroids help muscle development
Out of stock